Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo

Ovarian cancer is the leading cause of cancer death among gynecological malignancies. The high mortality rate has not been significantly reduced despite advances in surgery and chemotherapy. Gene therapy shows therapeutic potential, but several key issues must be resolved before clinical application...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ming-Xing, Hong, Shan-Shan, Cai, Qing-Qing, Zhang, Meng, Chen, Jun, Zhang, Xiao-Yan, Xu, Cong-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058609/
https://www.ncbi.nlm.nih.gov/pubmed/29542355
http://dx.doi.org/10.1080/10717544.2018.1451934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058609/
https://www.ncbi.nlm.nih.gov/pubmed/29542355
http://dx.doi.org/10.1080/10717544.2018.1451934

Ejemplares similares